An example of heterogeneous uptake of [89Zr]Zr-trastuzumab (i.e. HER2-mediated and passive accumulation) in a representative low HER-2 expressing MDA-MB-231 tumour can be observed in the magnified image shown in Fig. 7A (red). The gene discussed is ERBB2; the disease is neoplasm.